Cordis News and Activities

Cordis is owned by Hellman & Friedman.

Hellman & Friedman is one of the...

• Private Power;
• TOB Iconic 10,000.

Hellman & Friedman has a direct presence in 4 countries.

Hellman & Friedman has 15 subsidiaries including Caliber, Can-Sure and Cordis.

They are in:

• Insurance50%
• Medical Equipment25%
• Other25%

View the org chart displaying its 51 main executives

Most searched biographies at Cordis

• Scott Drake, Chief Executive Officer
• Karen Matusinec, Indpendent Director
• Chris Bingham, Vice President of Corporate Strategy & Business Dev...

Popular executive movements at Hellman & Friedman

• Gary Bischoping, Partner, will leave the company on May 8, 2026  (posted on March 4 2026).

Create your alert
to follow the executive moves at Cordis.

Hellman & Friedman has 1,247 competitors including Thermo Fisher Scientific (United States (USA)), Cytiva (United States (USA)) and Siemens Healthineers (Germany).

Popular M&A news in Medical Equipment

• Pearl Health has just announced a $110 Million fundraising (posted on July 12 2026).
• EQT has announced the acquisition of Corza Medical  (posted on July 9 2026).
• CVC Capital Partners has announced the acquisition of WillowWood  (posted on June 18 2026).

Popular contacts in Medical Equipment

• Ivan Tornos - Chairman, President and Chief Executive Officer at Zimmer Biomet
• Kweli Thompson - Executive Vice President and President, Neuroscience Portfolio at Medtronic
• Marc Casper - Chairman of the Board, President and Chief Executive Officer at Thermo Fisher Scientific

Learn more about the Medical Equipment industry

Press releases by Cordis

• SELUTION SLR PTA Drug-Eluting Balloon in Japan
• State of Florida and Cordis Announce Planned Investment
• Cordis to Present SELUTION SLR ™ DEB Clinical Data at CRT 2026
• Cordis Unveils Positive Results for Two SELUTON SLR DEB Trials
• Cordis to Unveil 12-Month SELUTION SLR DEB Trial Results
• Cordis Launches Global Coronary Registry for SELUTION SLR™…
• Cordis Announces Positive Results from Two Major Clinical Studies.
• Cordis Awarded Vascular Closure Devices Agreement with Premier, Inc.…
• Cordis receives FDA approval for MYNX CONTROL™ VENOUS Vascular…
• Cordis Announces Positive 24-Month Results from the SELUTION…
• View more press releases Close

Social media about Cordis

• Cordis on Wikipedia, Google News & Yahoo Finance
• Cordis on LinkedIn, X (Twitter) & YouTube